Omnitrope Articles

EMA advised Pfizer is withdrawing Thelin due to serious liver damage; starts somatropin drugs review

13 December 2010

Japanese Pharma market seeing more foreign entrants

21 January 2010

Global biosimilars product market worth $19.4 billion by 2014

2 September 2009

First Canadian biosimilar approved, amid mixed pharma industry reaction

27 April 2009

Sandoz gets FDA approval for Omnitrope

8 September 2008

Global biotechdrug market exceeds $75 billion in 2007, growing 12.5% on 2006

30 June 2008

EC approves more biosimilars, Stada and Hospira's epoetin zeta

7 January 2008

UPDATE: Sandoz' biosimilar epoetin cleared in EU

10 September 2007

Biosimilars outlook brighter on CHMP EPO recommendations and US Senate moves

20 August 2007

EMEA creates precedent for biosimilars with approvals for biogeneric versions of Epogen

2 July 2007

Biogenerics could "save $14B in Rx costs for Medicare Part B," claims report

15 January 2007

Less price flexibility, more innovation: the market dynamics of targeted therapeutics

16 October 2006

Branded biologic sales to plummet 60% by 2015

4 September 2006

Direct molecular evolution: lifecycle management for biologics

14 August 2006

Omnitrope's US appro sets no precedents for biogenerics, says Wood Mackenzie

19 June 2006

Sandoz/Novartis' Omnitrope is first "generic biological" to be approved by US FDA

12 June 2006

Sandoz plans five more "biosimilars" launches

22 May 2006

"Western biotechs not threatened by generic east," new study finds

8 May 2006

EC approves Sandoz' Omnitrope

24 April 2006

CHMP gives nod to Sandoz' Omnitrope

6 February 2006

EMEA opens the doors for "biosimilars" with Omnitrope

6 February 2006

First EU biogenerics "possible in 2006, but USA faces long and winding road:" study

30 January 2006

Novartis suit seeks FDA ruling on follow-on HGH

19 September 2005

Sandoz' Omnitrope OKed in Australia

11 October 2004

FDA defers decision on Sandoz' application for Omnitrope

13 September 2004

Showing 1-25 of 25 articles

Go to beginningPrevious
  • 1
NextGo to end